Soy Consumption and the Risk of Type 2 Diabetes and Cardiovascular Diseases: A Systematic Review and Meta-Analysis
Nutrients · 10.03.2023 · 15 (6) · 1358
DOI: 10.3390/nu15061358 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Nutrients, online erschienen am 10.03.2023. Verfasst von Xinrong Zuo und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, The Affiliated Hospital of Southwest Medical University, Luzhou 646000, China. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Diabetes Mellitus, Type 2, Soy Foods, Stroke. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Key Research Program of National Clinical Research Center for Geriatrics, the National Natural Science Foundation of China, the China Postdoctoral Science Foundation.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Soy is rich in plant protein, isoflavones, and polyunsaturated fatty acids. To clarify the associations between soy intake and type 2 diabetes (T2D) and cardiovascular diseases (CVDs) events, we performed a meta-analysis and review. A total of 1963 studies met the inclusion criteria, and 29 articles with 16,521 T2D and 54,213 CVDs events were identified by the eligibility criteria. During a follow-up of 2.5–24 years, the risk of T2D, CVDs, coronary heart disease, and stroke in participants with the highest soy consumption decreased by 17% (total relative risk (TRR) = 0.83, 95% CI: 0.74–0.93), 13% (TRR = 0.87, 95% CI: 0.81–0.94), 21% (TRR = 0.79, 95% CI: 0.71–0.88), and 12% (TRR = 0.88, 95% CI: 0.79–0.99), respectively, compared to the lowest sot consumption. A daily intake of 26.7 g of tofu reduced CVDs risk by 18% (TRR = 0.82, 95% CI: 0.74–0.92) and 11.1 g of natto lowered the risk of CVDs by 17% (TRR = 0.83, 95% CI: 0.78–0.89), especially stroke. This meta-analysis demonstrated that soy consumption was negatively associated with the risks of T2D and CVDs and a specific quantity of soy products was the most beneficial for the prevention of T2D and CVDs. This study has been registered on PROSPERO (registration number: CRD42022360504).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Anesthesiology, The Affiliated Hospital of Southwest Medical University, Luzhou 646000, China.
- Department of Anesthesiology, Laboratory of Mitochondria and Metabolism, National Clinical Research Center for Geriatrics, West China Hospital of Sichuan University, Chengdu 610041, China.
- Division of Gastrointestinal Surgery, West China Hospital of Sichuan University, Chengdu 610041, China.
ORCID-Profile: Minming Wu, Qianyi Wan, Tao Li
Förderung
- Key Research Program of National Clinical Research Center for Geriatrics
- the National Natural Science Foundation of China
- the China Postdoctoral Science Foundation
- Key Research and Development Program of Sichuan Province
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation
- Innovation Spark Project of Sichuan University
Zitieren
APA
Zuo, X., Zhao, R., Wu, M., Wan, Q., & Li, T. (2023). Soy Consumption and the Risk of Type 2 Diabetes and Cardiovascular Diseases: A Systematic Review and Meta-Analysis. Nutrients, 15(6), 1358. https://doi.org/10.3390/nu15061358
Vancouver
Zuo X, Zhao R, Wu M, Wan Q, Li T. Soy Consumption and the Risk of Type 2 Diabetes and Cardiovascular Diseases: A Systematic Review and Meta-Analysis. Nutrients. 2023;15(6):1358. doi:10.3390/nu15061358
BibTeX
@article{Zuo2023,
author = {Zuo, Xinrong and Zhao, Rui and Wu, Minming and Wan, Qianyi and Li, Tao},
title = {Soy Consumption and the Risk of Type 2 Diabetes and Cardiovascular Diseases: A Systematic Review and Meta-Analysis},
journal = {Nutrients},
year = {2023},
volume = {15},
number = {6},
pages = {1358},
doi = {10.3390/nu15061358}
}
EUVIMED